Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD [NA]

View source ↗

Summary

A clinical trial protocol evaluating self-administered transcranial direct current stimulation (tDCS) to improve single- and dual-task gait in Parkinson disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: Parkinson Disease | NA | Status: RECRUITING